Drug Delivery Postdoctoral Fellowship supports postdoctoral researchers pursuing drug formulation, dosage, and delivery research to make complex treatments safer, more effective, or easier to manage.
Funder: PhRMA Foundation
Due Dates: October 30, 2026, at 12:00 p.m. ET (Letter of intent) | March 2027 (Invited full application; exact deadline provided upon invitation)
Funding Amounts: $60,000 per year in stipend support for 12, 18, or 24 months
Summary: Supports multidisciplinary postdoctoral research training that advances therapeutically relevant drug formulation, dosage, and delivery.
Key Information: Only one applicant per laboratory may apply to Drug Delivery, choosing either a predoctoral or postdoctoral applicant.
The PhRMA Foundation’s Drug Delivery Postdoctoral Fellowship supports multidisciplinary, collaborative research training at accredited U.S. universities. Its scope includes basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, and biomedical engineering. The program seeks research that optimizes drug composition, dosage, and delivery to make increasingly complex treatments clinically viable, safer, more effective, or easier for patients to manage.
Supported work includes formulation and delivery technologies that enable desired pharmacokinetics and pharmacodynamics, manufacturing and quality-control processes for challenging chemical entities, and predictive approaches linking product quality to in vivo performance or delivery-system toxicity. Research applicable to multiple drug modalities is prioritized. Projects must identify a therapeutic payload, target tissue, and feasible dosing rationale; computational approaches require a translational validation plan.